Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05408247 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Randomised Controlled Trial of N-acetylcysteine for the Management of Alcohol Use Disorder

Study acronym: NAC-AUD
StatusRecruiting
PhasePhase 4
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated March 16, 2023 (before its estimated November 2025 completion). Its status may not reflect the trial's current state.

Record History

See every version on ClinicalTrials.gov ↗

  1. Notable Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Jan 2023 to Feb 16, 2023
    • Site details revised at 3 of 3 sites
    v5
  2. Notable Start date: Nov 2022 to Jan 2023v4
  3. Notable Lead sponsor: South West Sydney Local Health District to University of Sydneyv3 Show 6 more changesShow less
    • Start date: Aug 2022 to Nov 2022
    • Primary completion date: Aug 2025 to Nov 2025
    • Study completion date: Aug 2026 to Nov 2026
    • Secondary endpoints: 22 to 2
    • Collaborators: 2 to 1
    • Study description shortened, about 1 word
  4. Minor Study description revisedv2
  5. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
To explore the effectiveness of n-acetylcysteine in improving treatment outcomes for alcohol use disorder in a double-blind randomised placebo-controlled trial.
Trial Details
NCT Number NCT05408247
Lead Sponsor University of Sydney
Collaborators: Monash University
Conditions
(from sponsor)
Alcohol Use Disorder (AUD)
Related terms Alcoholism
Enrollment 280 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov